Brief: Immupharma Agrees With Avion For Phase 2/3 Adaptive Study Design For Lupus Study

ImmuPharma

06/02/2023 07:36

Feb 6 (Reuters) - ImmuPharma PLC  IMM.L :
    * IMMUPHARMA PLC  - LUPUZOR™ UPDATE
    * IMMUPHARMA PLC- PHASE 2/3 ADAPTIVE STUDY DESIGN FOR LUPUS
STUDY
AGREED WITH AVION

Source text for Eikon:  ID:nRSF9419Oa 
Further company coverage:  IMM.L 
 ((Reuters.Briefs@thomsonreuters.com;))